NCT02833558View on ClinicalTrials.gov

Purastat® vs Standard Therapy for Haemostasis During Endoscopic Submucosal Dissection

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 4, 2016

Primary Completion Date

April 12, 2018

Study Completion Date

May 18, 2018

Conditions
Gastrointestinal Haemorrhage
Interventions
DEVICE

PuraStat®

PuraStat® gel is applied through a safe catheter delivery system (via endoscope) over the bleeding point

PROCEDURE

Electrocautery

Electrocautery (coagulation current) to stop bleeding during ESD

Trial Locations (1)

PO6 3LY

Portsmputh Hospitals NHS Trust, Portsmouth

All Listed Sponsors
lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT02833558 - Purastat® vs Standard Therapy for Haemostasis During Endoscopic Submucosal Dissection | Biotech Hunter | Biotech Hunter